Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
August 28, 2017
Immune Pharmaceuticals Provides R&D and Business Update and Summary of Recent Financial Highlights
NEW YORK -- (BUSINESS WIRE) -- Immune Pharmaceuticals Inc. (IMNP) (“Immune” or the “Company”) provided the following R&D and business update and summary of recent financial ...
August 28, 2017
VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at The Immuno-Oncology Summit
CAMBRIDGE, MASSACHUSETTS--(Marketwired - Aug 28, 2017) - VBI Vaccines Inc. (VBIV)(VBV.TO) (VBI) today announced that David Anderson, Ph.D., Chief Scientific Officer of VBI, will present ...
August 28, 2017
Spring Bank to Present Additional Data from the First Cohort of its Ongoing SB 9200 ACHIEVE Clinical Trial at the 2017 International HBV Meeting in Washington D.C.
HOPKINTON, Mass., Aug. 28, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
August 28, 2017
La Jolla Pharmaceutical Company Announces U.S. FDA Acceptance of New Drug Application for LJPC-501
SAN DIEGO -- (BUSINESS WIRE) -- La Jolla Pharmaceutical Company (LJPC) (the Company or La Jolla) today announced that the U.S. Food and Drug Administration (FDA) has ...
August 25, 2017
Kiadis Pharma Announces Financial Results for the Six Months Ended June 30, 2017
AMSTERDAM-DUIVENDRECHT, Netherlands -- (BUSINESS WIRE) -- Regulatory News: Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing ...
August 25, 2017
Kedrion Biopharma and Kamada Receive FDA Approval of KEDRAB™ for Post-Exposure Prophylaxis Against Rabies Infection
FORT LEE, N.J. & REHOVOT, Israel - -(BUSINESS WIRE) -- Kedrion Biopharma and Kamada Ltd. (NASDAQ and TASE:KMDA), two leading human-derived protein therapeutics companies, today announced ...
August 25, 2017
Zealand grants new warrants under employee warrant program
Copenhagen, August 25, 2017 - Zealand announces the grant of warrants to the Company`s President and CEO Britt Meelby Jensen. The warrants are granted under ...
August 25, 2017
Minerva Neurosciences Announces European Commission Approval of Amendment of MIN-202 Agreement With Janssen
WALTHAM, Mass., Aug. 25, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
August 23, 2017
BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman
RALEIGH, N.C., Aug. 23, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) announced today that at the end of 2017, Dr. Mark A. Sirgo will ...
August 23, 2017
ADMA Biologics to Present at Upcoming Investor Conferences
RAMSEY, N.J., Aug. 23, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated biopharmaceutical and specialty immunoglobulin company that ...
August 23, 2017
AzurRx Reaches 6th Patient Enrollment of Phase IIa Trial of MS1819 for Treatment of Exocrine Pancreatic Insufficiency Associated with Chronic Pancreatitis
BROOKLYN, N.Y., Aug. 23, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant ...
August 22, 2017
Paratek Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
BOSTON, Aug. 22, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) today announced that the Company will participate in five upcoming investor conferences. Paratek is ...
August 22, 2017
Phase 1 trials for two novel treatments of obesity and/or diabetes initiated by Zealand partner Boehringer Ingelheim
Copenhagen, August 22, 2017 - Zealand Pharma A/S ("Zealand") reports that Boehringer Ingelheim has announced the initiation of two Phase 1 trials, the first with ...
August 22, 2017
AC IMMUNE DISCOVERS NEXT-GENERATION ANTIBODIES FOCUSED ON NEURODEGENERATIVE DISEASES
Lausanne, Switzerland, August 22, 2017 - AC Immune SA (ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today ...
August 17, 2017
TherapeuticsMD Announces Publication of Manuscript on the Women’s Health Initiative Observational Study of Vaginal Estrogen Use in Postmenopausal Women
BOCA RATON, Fla. -- (BUSINESS WIRE) -- TherapeuticsMD, Inc. (NYSE MKT:TXMD), an innovative women’s healthcare company, today announced the publication of the manuscript detailing results of ...
August 17, 2017
Kitov Pharmaceuticals Provides Corporate Update and Reports First Half 2017 Financial Results
TEL AVIV, Israel, Aug. 16, 2017 /PRNewswire/ -- Kitov Pharmaceuticals Holdings Ltd. (KTOV) (KTOV), an innovative biopharmaceutical company, today provided a corporate update and reported ...
August 17, 2017
Kiadis Pharma obtains up to €15 million debt financing from Kreos Capital
AMSTERDAM-DUIVENDRECHT, The Netherlands -- (BUSINESS WIRE) -- Regulatory News: Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company ...
August 17, 2017
AgeX Therapeutics Closes $10 Million Capital Raise
ALAMEDA, Calif. -- (BUSINESS WIRE) -- AgeX Therapeutics, Inc. (AgeX), a subsidiary of BioTime, Inc. (NYSE American: BTX), announced today that it has closed its round ...
August 17, 2017
BioDelivery Sciences to Present Three Posters on BELBUCA® and BUNAVAIL® at PAINWeek 2017
RALEIGH, N.C., Aug. 17, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) will present three posters reviewing the potential impacts of BELBUCA®(buprenorphine) buccal film (CIII) and ...
August 17, 2017
Altimmune Announces $14.7 Million Series B Preferred Stock Offering
GAITHERSBURG, Md., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced it has entered into a definitive securities purchase ...
Page 96 of 117